3547 results for «221»
3547 results
Complex heart problems in cancer patients
19 May 2022 – From EuroPCR 2022
TAVI and thrombocytopenia, TAVI, CAD and hepatocarcinoma, or even severe aortic regurgitation and ovarian cancer with infective endocarditis: analyze the case of different cancer patients to be treated for cardiac pathologies in this session from EuroPCR 2022.
The cathlab of tomorrow... already here today
18 May 2022 – From EuroPCR 2022
Explore the 3 key pillars of innovation and discover how AI can improve patient safety and aid decision-making in the cathlab, what are the latest updates in robotic PCI and how it can be the transformative technology, and how technology can have a huge impact on...
SWISS-APERO: a randomized trial of the amulet versus watchman FLX devices for left atrial appendage closure
04 Nov 2021
The SWISS-APERO is a prospective, investigator-initiated, randomized, multi-center, and clinical trial designed to compare the Amulet and Watchman (2.5 and FLX) devices in a head-to-head fashion.
Author
Mid-term echocardiographic outcomes following transapical mitral valve replacement: Updates from the Intrepid Pilot Study
19 Sep 2022
Pamela Gatto provides her take on the Intrepid Global Pilot Study which was presented by Renuka Jain at TCT Congress 2022.
Author
Post-TAVI cardiac arrest associated to acute coronary occlusion: facing the storm to gain calm
26 Jan 2024
Observe this TAVI case featuring pulseless electrical activity due to an unforeseen acute occlusion of the right coronary artery, and discover the strategies employed to address and resolve this critical complication.
Authors :
Five-year clinical and echocardiographic outcomes from the PARTNER 3 Low-Risk randomized trial
26 Oct 2023
Alex Sticchi provides his take on the 5-year outcomes from PARTNER 3 Low Risk which were presented by Martin B. Leon at TCT Congress 2023.
Author
PROSPECT II, COMBINE (OCT–FFR) and PROSPECT ABSORB: After revascularization of culprit lesions, assessment of coronary plaque size and composition matter!
17 Oct 2020
PROSPECT II, COMBINE (OCT–FFR) and PROSPECT ABSORB trials were presented at TCT Connect 2020. Hector Garcia-Garcia provides a summary of the key messages.
Author
